Risorse per la formazione
I programmi di formazione e le risorse di EURORDIS sono stati sviluppati per rafforzare la capacità dei rapprensentanti dei malati di partecipare alle sperimentazioni cliniche e di essere coinvolti nello sviluppo dei farmaci e nel processo legislativo europeo. La formazione rafforza la capacità dei rappresentanti dei malati di promuovere con efficacia la causa delle malattie rare.
.
Clinical Research
Markku Toivonen Toivonen, MD, PhD Scientific Director NDA Regulatory Science Ltd gives a presentation entiled Clinical trials: When and why? ...
Statistics
Dr Ferran Torres Statistics and Methodology Support Unit, Hospital Clinic, Barcelona on the Analysis and Interpretation of Clinical Trials...
Regulatory Procedures
Patrick Salmon Irish Medicines Board introduces the EURORDIS Summer School attendees to the Regulatory Procedures at the EMEA...
Ethics
Dr. Eric Koster speaks gives a presentation entitles ETHICAL ASPECTS OF MEDICAL RESEARCH INVOLVING HUMAN SUBJECTS...
Clinical Trials in Non-Standard Situations
Markku Toivonen Toivonen, MD, PhD Scientific Director NDA Regulatory Science Ltd gives a presentation entiled Clinical Trials in Non-Standard Situations...
The European Medicines Agency (EMA)
Dr Juan Garcia Burgos from the EMA Medical Information Sector introduces the agency's work...
The Committee on Orphan Medicinal Products (COMP)
Yann le Cam CEO of EURORDIS introduces the Committee on Orphan Medicinal Products (COMP) at the European Medicine's Agency ...
The Paediatric Committee (PDCO)
Dr. Fernando de Andres gives a presenation entitles The regulation on pediatric medicines, a fresh approach to stimulate research on medicines for children: The Paediatric Committee: (PDCO)...
The Committee on Human Medicinal Products(CHMP)
Patrick Salmon Irish Medicines Board introduces the EURORDIS Summer School attendees to the Committee on Human Medicinal Products(CHMP) at the European Medicine's Agency ...
